Last updated: February 21, 2026
What is the scope of patent MX2012006764?
Patent MX2012006764 pertains to a pharmaceutical invention filed in Mexico. Its scope covers specific formulations, methods of manufacturing, or uses for a designated active ingredient or combination. The patent’s claims define the extent of legal protection around the invention.
The patent likely claims a novel composition, process, or use that distinguishes it from prior art. These claims are divided into independent and dependent claims:
- Independent claims: Encompass the core inventive concept, such as a new drug formulation or synthesis method.
- Dependent claims: Cover variations or specific embodiments of the invention.
The exact scope depends on the language of the claims, which must clearly specify the novel aspects to avoid overlap with prior art and to meet patentability standards.
What are the key claims of MX2012006764?
Without full claim text available, typical patent claims for pharmaceutical inventions include:
- Composition claims, such as a formulation comprising specific amounts of active ingredients.
- Method claims, describing a process of manufacturing or administering the drug.
- Use claims, covering treatment methods involving the drug.
For example, the patent might claim:
- A pharmaceutical composition comprising a specified active pharmaceutical ingredient (API), a carrier, and a stabilizer.
- A method of producing the API through a particular synthesis pathway.
- The use of the drug for treating a specific disease or condition.
Reviewing the claims reveals their breadth—larger scope increases market control but may face higher patent invalidation risk if challenged.
How does the patent landscape look in Mexico for pharmaceuticals related to MX2012006764?
Mexico’s patent landscape for pharmaceuticals exhibits characteristics typical of emerging markets:
- Patent filings: Mexico has steadily increased its drug patent filings, with annual growth rates averaging around 7-10% over the past decade.
- Patent life: The standard term is 20 years from the filing date, with some extensions possible under regulatory data exclusivity.
- Major players: Multinational pharma companies and local firms actively file patents, including compound patents, formulations, and process patents.
- Patent challenges: Flexibility exists for patent invalidation—particularly for process claims—under Mexican law, which emphasizes patent disclosures and inventive step.
The Mexican patent office (IMPI) follows the Patent Cooperation Treaty (PCT), enabling applicants to seek patent protections across multiple jurisdictions with streamlined procedures.
Notable patent landscapes influencing MX2012006764
- Overlap with international patents: Similar compounds or formulations may be protected elsewhere, affecting the scope of Mexican rights.
- Patent thickets: Multiple patents in related areas can complicate freedom-to-operate assessments.
- Legal precedents: Mexican courts have invalidated patents for insufficient inventive step or lack of novelty, influencing how claims are drafted.
Regulatory considerations influencing patent scope
In Mexico, drug patents intersect with regulatory data exclusivity—generally 5 years for new drugs—potentially limiting generic entry despite patent expiry. The patent scope should consider the distinction between proprietary formulations and regulatory exclusivities.
Summary
- MX2012006764 likely claims a specific pharmaceutical composition, manufacturing process, or therapeutic use.
- Its scope is as broad as the language of the claims allows but is vulnerable to prior art or validity challenges under Mexican law.
- The Mexican patent landscape is active, with significant filings and legal challenges that impact the protection of pharmaceutical inventions.
Key Takeaways
- The scope hinges on the wording of claims; clarity and specificity are crucial.
- Mexican patent law emphasizes inventive step and novelty, influencing claim robustness.
- Patent expiry is usually 20 years from filing; however, regulatory protections may extend exclusivity.
- Patent landscapes in Mexico include active filings, potential patent thickets, and legal hurdles.
- Cross-jurisdictional patent rights and regulatory policies can influence enforcement and commercialization strategy.
FAQs
What types of claims are typical in pharmaceutical patents like MX2012006764?
They include composition claims, process claims, and use claims for specific therapeutic applications.
How does Mexican patent law treat patent invalidation?
Claims can be invalidated if they lack novelty, inventive step, or sufficient disclosure, similar to other jurisdictions.
What is the standard patent term in Mexico?
20 years from the filing date, with possible extensions under certain conditions, such as data exclusivity.
What impact do regulatory data exclusivity periods have on patent protection?
They can prevent generic registration during their duration, even if patent rights have expired.
How does Mexico’s participation in the PCT influence patent filings?
It simplifies multi-jurisdictional filing, enabling broader patent protection with a unified application process.
References
[1] Mexican Institute of Industrial Property. (2022). Guide to Patent Law in Mexico. IMPI.
